Cadrenal Therapeutics Provides First Quarter 2024 Corporate Update

Go back to Cadrenal Therapeutics Provides First Quarter 2024 Corporate Update
(NASDAQ: CVKD) Delayed: 1.64 -0.07 (4.09%)
Previous Close $1.71    52 Week High
Open $1.75    52 Week Low
Day High $1.78    P/E N/A 
Day Low $1.62    EPS
Volume 81,000